吉林敖东：控股子公司获10个中药配方颗粒上市备案凭证

Core Viewpoint - Jilin Aodong announced that its subsidiary Yanbian Pharmaceutical has obtained 10 new "Traditional Chinese Medicine Formula Granule Listing Registration Certificates," which include products like Solanum Nigrum Formula Granule and Tianquizi Formula Granule. This development is significant for the company's expansion in the traditional Chinese medicine formula granule business and enhances its core competitiveness. However, product sales are subject to market environment influences, leading to uncertainty, and it is expected that there will be no major impact on performance in the short term [1]. Group 1 - Yanbian Pharmaceutical has received a total of 10 new listing registration certificates for traditional Chinese medicine formula granules [1]. - The total number of such certificates held by Yanbian Pharmaceutical has reached 535 [1]. - The new certificates are expected to significantly aid in the expansion of the company's traditional Chinese medicine formula granule business [1]. Group 2 - The company acknowledges that product sales may be affected by market conditions, introducing an element of uncertainty [1]. - It is anticipated that the recent developments will not have a substantial impact on the company's performance in the short term [1].